MiRNA-21

References

• Shen HB, Yu SZ. Epidemiological status of lung cancer in China and strategies for prevention. Bulletin Chinese Cancer 2004; 5:283 - 5
   Google Scholar
• Gurubhagavatula S, Lynch TJ. The role of adjuvant chemotherapy for non-small cell lung cancer. Semin Respir Crit Care Med 2005; 26:298 - 303; http://dx.doi.org/10.1055/s-2005-871988; PMID: 16052431
   PubMed Web of Science ®Google Scholar
• Sève P, Dumontet C. Chemoresistance in non-small cell lung cancer. Curr Med Chem Anticancer Agents 2005; 5:73 - 88; http://dx.doi.org/10.2174/1568011053352604; PMID: 15720263
   PubMedGoogle Scholar
• Yin M, Yan J, Voutsina A, Tibaldi C, Christiani DC, Heist RS, et al. No evidence of an association of ERCC1 and ERCC2 polymorphisms with clinical outcomes of platinum-based chemotherapies in non-small cell lung cancer: A meta-analysis. Lung Cancer 2011; In press PMID: 21075476
   PubMed Web of Science ®Google Scholar
• Ruan K, Fang X, Ouyang G. MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett 2009; 285:116 - 26; http://dx.doi.org/10.1016/j.canlet.2009.04.031; PMID: 19464788
   PubMed Web of Science ®Google Scholar
• Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 2006; 130:2113 - 29; http://dx.doi.org/10.1053/j.gastro.2006.02.057; PMID: 16762633
   PubMed Web of Science ®Google Scholar
• Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY. miR-21-mediated tumor growth. Oncogene 2007; 26:2799 - 803; http://dx.doi.org/10.1038/sj.onc.1210083; PMID: 17072344
   PubMed Web of Science ®Google Scholar
• Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 2008; 68:425 - 33; http://dx.doi.org/10.1158/0008-5472.CAN-07-2488; PMID: 18199536
   PubMed Web of Science ®Google Scholar
• Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435:834 - 8; http://dx.doi.org/10.1038/nature03702; PMID: 15944708
   PubMed Web of Science ®Google Scholar
• Liu LZ, Zhou XD, Qian G, Shi X, Fang J, Jiang B. HAKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway. Cancer Res 2007; 67:6325 - 32; http://dx.doi.org/10.1158/0008-5472.CAN-06-4261; PMID: 17616691
   PubMed Web of Science ®Google Scholar
• Li JJ, Ding Y, Li DD, Peng RQ, Feng GK, Zeng YX, et al. The overexpression of ERCC-1 is involved in the resistance of lung cancer cells to cetuximab combined with DDP. Cancer Biol Ther 2009; 8:1914 - 21; http://dx.doi.org/10.4161/cbt.8.20.9439; PMID: 20009541
   PubMed Web of Science ®Google Scholar
• Akao Y, Noguchi S, Iio A, Kojima K, Takagi T, Naoe T. Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells. Cancer Lett 2011; 300:197 - 204; http://dx.doi.org/10.1016/j.canlet.2010.10.006; PMID: 21067862
   PubMed Web of Science ®Google Scholar
• Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S, et al. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 2008; 123:372 - 9; http://dx.doi.org/10.1002/ijc.23501; PMID: 18449891
   PubMed Web of Science ®Google Scholar
• Kovalchuk O, Filkowski J, Meservy J, Ilnytskyy Y, Tryndyak VP, Chekhun VF, et al. Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther 2008; 7:2152 - 9; http://dx.doi.org/10.1158/1535-7163.MCT-08-0021; PMID: 18645025
   PubMed Web of Science ®Google Scholar
• Gao W, Yu Y, Cao HL, Shen H, Li XD, Pan SY. Deregulated expression of miR-21, miR-143 and s miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Biomed Pharmacother 2010; 64:399 - 408; http://dx.doi.org/10.1016/j.biopha.2010.01.018; PMID: 20363096
   PubMed Web of Science ®Google Scholar
• Blower PE, Chung JH, Verducci JS, Lin S, Park JK, Dai Z, et al. MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther 2008; 7:1 - 9; http://dx.doi.org/10.1158/1535-7163.MCT-07-0573; PMID: 18187804
   PubMed Web of Science ®Google Scholar
• Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, et al. MiRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 2008; 14:2348 - 60; http://dx.doi.org/10.1261/rna.1034808; PMID: 18812439
   PubMed Web of Science ®Google Scholar
• Huang GL, Zhang XH, Guo GL, Huang KT, Yang KY, Shen X, et al. Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma. Oncol Rep 2009; 21:673 - 9; PMID: 19212625
   PubMed Web of Science ®Google Scholar
• Hummel R, Hussey DJ, Michael MZ, Haier J, Bruewer M, Senninger N. MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma. Ann Surg Oncol 2011; 18:253 - 60; http://dx.doi.org/10.1245/s10434-010-1213-y; PMID: 20628822
   PubMed Web of Science ®Google Scholar
• Dillhoff M, Liu J, Frankel W, Croce C. Bloomston. MMicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J Gastrointest Surg 2008; 12:2171 - 6; http://dx.doi.org/10.1007/s11605-008-0584-x; PMID: 18642050
   PubMed Web of Science ®Google Scholar
• Shibuya H, Iinuma H, Shimada R, Horiuchi A, Watanabe T. Clinicopathological and Prognostic Value of MicroRNA-21 and MicroRNA-155 in Colorectal Cancer. Oncology 2010; 79:313 - 20; http://dx.doi.org/10.1159/000323283; PMID: 21412018
   PubMed Web of Science ®Google Scholar
• Markou A, Tsaroucha EG, Kaklamanis L, Fotinou M, Georgoulias V, Lianidou ES. Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin Chem 2008; 54:1696 - 704; http://dx.doi.org/10.1373/clinchem.2007.101741; PMID: 18719201
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stableblood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105:10513 - 8; http://dx.doi.org/10.1073/pnas.0804549105; PMID: 18663219
   PubMed Web of Science ®Google Scholar
• Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterizationof miRNAs in serum: a novel classof biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18:997 - 1006; http://dx.doi.org/10.1038/cr.2008.282; PMID: 18766170
   PubMed Web of Science ®Google Scholar
• Huang Z, Huang D, Ni SJ, Peng ZL, Sheng WQ, Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010; 127:118 - 26; http://dx.doi.org/10.1002/ijc.25007; PMID: 19876917
   PubMed Web of Science ®Google Scholar
• Slaby O, Svoboda M, Michalek J. Vyzula RMicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer 2009; 8:102; http://dx.doi.org/10.1186/1476-4598-8-102; PMID: 19912656
   PubMed Web of Science ®Google Scholar
• Zhu W, Qin W, Atasoy U, Sauter ER. Circulating microRNAs in breast cancer and healthy subjects. BMC Research Notes 2009; 2:89; http://dx.doi.org/10.1186/1756-0500-2-89; PMID: 19454029
   PubMedGoogle Scholar
• Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, et al. Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non–Small-Cell Lung Cancer. J Clin Oncol 2010; 28:1721 - 6; http://dx.doi.org/10.1200/JCO.2009.24.9342; PMID: 20194856
   PubMed Web of Science ®Google Scholar
• Rabinowits G, Gerçel-Taylor C, Day JM, Taylor DD, Kloecker GH. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 2009; 10:42 - 6; http://dx.doi.org/10.3816/CLC.2009.n.006; PMID: 19289371
   PubMed Web of Science ®Google Scholar
• Bai H, Mao L, Wang HS, Zhao J, Yang L, An TT, et al. Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer. J Clin Oncol 2009; 27:2653 - 9; http://dx.doi.org/10.1200/JCO.2008.17.3930; PMID: 19414683
   PubMed Web of Science ®Google Scholar
• Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 2009; 112:55 - 9; http://dx.doi.org/10.1016/j.ygyno.2008.08.036; PMID: 18954897
   PubMed Web of Science ®Google Scholar
• Wei J, Gao W, Zhu CJ, Liu YQ, Mei Z, Cheng T, et al. Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer. Chin J Cancer 2011; 30:407 - 14; http://dx.doi.org/10.5732/cjc.010.10522; PMID: 21627863
   PubMedGoogle Scholar
• Filipits M, Pirker R. Predictive markers in the adjuvant therapy of non-small cell lung cancer. Lung Cancer 2011; 74:355 - 63; http://dx.doi.org/10.1016/j.lungcan.2011.06.005; PMID: 21885151
   PubMed Web of Science ®Google Scholar
• Horn L, Sandler AB. Emerging data with antiangiogenic therapies in early and advanced non-small-cell lung cancer. Clin Lung Cancer 2009; 10:Suppl 1 S7 - 16; http://dx.doi.org/10.3816/CLC.2009.s.002; PMID: 19362948
   PubMedGoogle Scholar
• Higgins MJ, Ettinger DS. Chemotherapy for lung cancer: the state of the art in 2009. Expert Rev Anticancer Ther 2009; 9:1365 - 78; http://dx.doi.org/10.1586/era.09.115; PMID: 19827996
   PubMed Web of Science ®Google Scholar
• Matsenko NU, Rijikova VS, Kovalenko SP. Comparison of SYBR Green I and TaqMan real-time PCR formats for the analysis of her2 gene dose in human breast tumors. Bull Exp Biol Med 2008; 145:240 - 4; http://dx.doi.org/10.1007/s10517-008-0060-3; PMID: 19023979
   PubMed Web of Science ®Google Scholar
• Jamnikar Ciglenecki U, Grom J, Toplak I, Jemersić L, Barlic-Maganja D. Real-time RT-PCR assay for rapid and specific detection of classical swine fever virus: comparison of SYBR Green and TaqMan MGB detection methods using novel MGB probes. J Virol Methods 2008; 147:257 - 64; http://dx.doi.org/10.1016/j.jviromet.2007.09.017; PMID: 18001851
   PubMed Web of Science ®Google Scholar
• Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada KM. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 1998; 280:1614 - 7; http://dx.doi.org/10.1126/science.280.5369.1614; PMID: 9616126
   PubMed Web of Science ®Google Scholar
• Losert D, Pratscher B, Soutschek J, Geick A, Vornlocher HP, Müller M, et al. Bcl-2 downregulation sensitizes non-small cell lung cancer cells to cisplatin, but not to docetaxel. Anticancer Drugs 2007; 18:755 - 61; http://dx.doi.org/10.1097/CAD.0b013e3280adc8c8; PMID: 17581297
   PubMed Web of Science ®Google Scholar
• Roberti A, La Sala D, Cinti C. Multiple genetic and epigenetic interacting mechanisms contribute to clonally selection of drug-resistant tumors: current views and new therapeutic prospective. J Cell Physiol 2006; 207:571 - 81; http://dx.doi.org/10.1002/jcp.20515; PMID: 16250021
   PubMed Web of Science ®Google Scholar
• Ishii T, Teramoto S, Matsuse T. GSTP1 affects chemoresistance against camptothecin in human lung adenocarcinoma cells. Cancer Lett 2004; 216:89 - 102; http://dx.doi.org/10.1016/j.canlet.2004.05.018; PMID: 15500952
   PubMed Web of Science ®Google Scholar
• Cortes-Dericks L, Carboni GL, Schmid RA, Karoubi G. Putative cancer stem cells in malignant pleural mesothelioma show resistance to cisplatin and pemetrexed. Int J Oncol 2010; 37:437 - 44; PMID: 20596671
   PubMed Web of Science ®Google Scholar
• Dallas NA, Xia L, Fan F, Gray MJ, Gaur P, van Buren G 2nd, et al. Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res 2009; 69:1951 - 7; http://dx.doi.org/10.1158/0008-5472.CAN-08-2023; PMID: 19244128
   PubMed Web of Science ®Google Scholar
• Bao B, Ali S, Kong D, Sarkar SH, Wang Z, Banerjee S. Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer. PLoS ONE 2011; 6:e17850; http://dx.doi.org/10.1371/journal.pone.0017850; PMID: 21408027
   PubMedGoogle Scholar
• Misawa A, Katayama R, Koike S, Tomida A, Watanabe T, Fujita N. AP-1-Dependent miR-21 expression contributes to chemoresistance in cancer stem cell-like SP cells. Oncol Res 2010; 19:23 - 33; http://dx.doi.org/10.3727/096504010X12828372551759; PMID: 21141738
   PubMed Web of Science ®Google Scholar
• Elkan-Miller T, Ulitsky I, Hertzano R, Rudnicki A, Dror AA, Lenz DR, et al. Avraham,Integration of Transcriptomics, Proteomics, and MicroRNA Analyses Reveals Novel MicroRNA Regulation of Targets in the Mammalian Inner Ear. PLoS ONE 2011; 6:e18195; http://dx.doi.org/10.1371/journal.pone.0018195; PMID: 21483685
   PubMedGoogle Scholar
• Eitan R, Kushnir M, Lithwick-Yanai G, David MB, Hoshen M, Glezerman M, et al. Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients. Gynecol Oncol 2009; 114:253 - 9; http://dx.doi.org/10.1016/j.ygyno.2009.04.024; PMID: 19446316
   PubMed Web of Science ®Google Scholar
• Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009; 58:1375 - 81; http://dx.doi.org/10.1136/gut.2008.167817; PMID: 19201770
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)). Method. Methods 2001; 25:402 - 8
   PubMed Web of Science ®Google Scholar
• Liu CJ, Kao SY, Tu HF, Tsai MM, Chang KW, Lin SC. Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. Oral Dis 2010; 16:360 - 4; http://dx.doi.org/10.1111/j.1601-0825.2009.01646.x; PMID: 20233326
   PubMed Web of Science ®Google Scholar
• Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI. Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue. Clin Cancer Res 2008; 14:2588 - 92; http://dx.doi.org/10.1158/1078-0432.CCR-07-0666; PMID: 18451220
   PubMed Web of Science ®Google Scholar